Abstract
Lithium treatment history goes far back before it was thoroughly described in the literature which is now available to us. However, disorders that were initially treated with lithium salts were completely unrelated to psychiatry. The article “Lithium salts in the treatment of psychotic excitement” from 1949 written by John Cade is considered to be the introduction of lithium to modern psychiatric therapy and the beginning of modern clinical psychopharmacology.
In the present treatment guidelines for bipolar disorders lithium is recommended as a first-line maintenance therapy. What is worth mentioning is that the number of indications, including major depressive disorder, for instance, is growing. In addition, numerous meta-analyses focused on antisuicidal effect of lithium therapy were also performed.
On the basis of the most recent literature available in this paper we presented indications for the preventive use of lithium for such disorders as mania, bipolar disorder as well as the occurrence of depressive episodes in major depressive disorder. It is worth pointing out that some studies indicate lithium to be the only medicine proved to be effective for mood stabilization. Interactions between lithium and other medicines were described in detail. In this paper we also described and discussed possible side effects of lithium therapy, including renal failure, hypothyroidism, hyperparathyroidism, weight gain and teratogenicity.
Keywords: Bipolar disorder, depression, lithium, mania, meta-analysis, suicide.
Current Psychopharmacology
Title:Lithium in Psychiatry-The Benefits and Risks Associated with the Lithium Salts Treatment in Affective Disorders
Volume: 3 Issue: 1
Author(s): Joanna Iskra-Trifunovic, Mateusz Szymczak, Andrzej Jasiewicz, Anna Grzywacz and Jerzy Samochowiec
Affiliation:
- Department of Psychiatry, Pomeranian Medical University, 26 Broniewskiego, 71-460 Szczecin, Poland.,Poland
Keywords: Bipolar disorder, depression, lithium, mania, meta-analysis, suicide.
Abstract: Lithium treatment history goes far back before it was thoroughly described in the literature which is now available to us. However, disorders that were initially treated with lithium salts were completely unrelated to psychiatry. The article “Lithium salts in the treatment of psychotic excitement” from 1949 written by John Cade is considered to be the introduction of lithium to modern psychiatric therapy and the beginning of modern clinical psychopharmacology.
In the present treatment guidelines for bipolar disorders lithium is recommended as a first-line maintenance therapy. What is worth mentioning is that the number of indications, including major depressive disorder, for instance, is growing. In addition, numerous meta-analyses focused on antisuicidal effect of lithium therapy were also performed.
On the basis of the most recent literature available in this paper we presented indications for the preventive use of lithium for such disorders as mania, bipolar disorder as well as the occurrence of depressive episodes in major depressive disorder. It is worth pointing out that some studies indicate lithium to be the only medicine proved to be effective for mood stabilization. Interactions between lithium and other medicines were described in detail. In this paper we also described and discussed possible side effects of lithium therapy, including renal failure, hypothyroidism, hyperparathyroidism, weight gain and teratogenicity.
Export Options
About this article
Cite this article as:
Iskra-Trifunovic Joanna, Szymczak Mateusz, Jasiewicz Andrzej, Grzywacz Anna and Samochowiec Jerzy, Lithium in Psychiatry-The Benefits and Risks Associated with the Lithium Salts Treatment in Affective Disorders, Current Psychopharmacology 2014; 3(1) . https://dx.doi.org/10.2174/2211556003666140319231533
DOI https://dx.doi.org/10.2174/2211556003666140319231533 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Short Guide
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Inflammatory Mediators in Epilepsy
Current Pharmaceutical Design Antiphospholipid Syndrome as a Neurological Disease
Current Rheumatology Reviews Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets Role of Natural Plant Products Against Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets Driving Cellular Plasticity and Survival Through the Signal Transduction Pathways of Metabotropic Glutamate Receptors
Current Neurovascular Research Mechanisms and Treatment of Neuropathic Pain
Central Nervous System Agents in Medicinal Chemistry Targeting Oxidative Stress Component in the Therapeutics of Epilepsy
Current Topics in Medicinal Chemistry PET Imaging in Clinical Drug Abuse Research
Current Pharmaceutical Design Conventional and New Antiepileptic Drugs on Vitamin D and Bone Health: What We Know to Date?
Current Clinical Pharmacology Kynurenine Pathway and Disease: An Overview
CNS & Neurological Disorders - Drug Targets The Evolution of Histamine H3 Antagonists/Inverse Agonists
Current Topics in Medicinal Chemistry Nanotechnology and Drug Delivery: Getting There is Only Half of the Challenge! (Commentary)
CNS & Neurological Disorders - Drug Targets Developmental Expression and Dysregulation of miR-146a and miR-155 in Down's Syndrome and Mouse Models of Down's Syndrome and Alzheimer's Disease
Current Alzheimer Research Endocrine Disruptors and Human Health
Mini-Reviews in Medicinal Chemistry Which Dose of Folic Acid Should Pregnant Diabetic Women Receive?
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Novel Neuroendocrine and Metabolic Mechanism Provides the Patented Platform for Important Rejuvenation Therapies: Targeted Therapy of Telomere Attrition and Lifestyle Changes of Telomerase Activity with the Timing of Neuron-Specific Imidazole-Containing Dipeptide-Dominant Pharmaconutrition Provision
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Development and Validation of 'Level A' In Vitro - In Vivo Correlation for Extended Release Tablets of Lamotrigine
Current Bioactive Compounds Gene Therapy Repairs for the Epileptic Brain: Potential for Treatment and Future Directions
Current Gene Therapy The Role of Melatonin in the Immuno-Neuro-Psychology of Mental Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Immunotoxins Constructed with Ribosome-Inactivating Proteins and their Enhancers: A Lethal Cocktail with Tumor Specific Efficacy
Current Pharmaceutical Design